Dr. Markus Templin
Group Leader Assay Development
- 2003 - today
- Group Leader Assay Development
- 2000 - today
- NMI
- 1996 - 2000
- Research Associate at the Max Planck Institute for Developmental Biology in Tübingen, Germany
- 1994 - 1995
- Postdoktorand, ICMB, Universität von Edinburgh, Schottland, UK
- 1983 - 1990
- Diploma in Biology, University of Tübingen
After completing his doctorate at the University of Tübingen in 1994, he started working as a scientist at the NMI in 2000 and has been group leader of the Assay Development group since 2003. His research interests include cellular signal transduction, antibody-based proteomics, and protein analysis and method development.
Selected publications
- A bead-based western for high-throughput cellular signal transduction analyses Treindl F, Ruprecht B, Beiter Y, Schultz S, Dottinger A, Staebler A, Joos TO, Kling S, Poetz O, Fehm T, Neubauer H, Kuster B, Templin MF Nat Commun. 2016 doi: 10.1038/ncomms12852
- A high-throughput pipeline for validation of antibodies Sikorski K, Mehta A, Inngjerdingen M, Thakor F, Kling S, Kalina T, Nyman TA, Stensland ME, Zhou W, de Souza GA, Holden L, Stuchly J, Templin M, Lund-Johansen F Nat Methods. 2018 doi: 10.1038/s41592-018-0179-8
- Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2. Fink S, Ruoff F, Stahl A, Becker M, Kaiser P, Traenkle B, Junker D, Weise F, Ruetalo N, Hörber S, Peter A, Nelde A, Walz J, Krause G, Baillot A, Schenke-Layland K, Joos TO, Rothbauer U, Schneiderhan-Marra N, Schindler M, Templin MF ACS Infect Dis. 2021 doi: 10.1021/acsinfecdis.0c00725
- Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome. Ruoff F, Kersten N, Anderle N, Jerbi S, Stahl A, Koch A, Staebler A, Hartkopf A, Brucker SY, Hahn M, Schenke-Layland K, Schmees C, Templin MF Cancers 2022 doi: 10.3390/cancers14184542
- Characterization of hepatic zonation in mice by mass-spectrometric and antibody-based proteomics approaches. Kling S, Lang B, Hammer HS, Naboulsi W, Sprenger H, Frenzel F, Pötz O, Schwarz M, Braeuning A, Templin MF Biol Chem 2022 doi: 10.1515/hsz-2021-0314. Print 2022 Feb 23
ORCID: 0000-0002-6569-6489
NMI Natural and Medical Sciences Institute
at the University of Tübingen
Markwiesenstraße 55, 72770 Reutlingen
Tel.: +49 7121 51530-0
Mail: info@nmi.de
Follow us now
